Category - GHP News

GHP News Latest Science

Needle-free pan-sarbecovirus vaccine clears phase 1 safety milestone, but broad protection remains unproven

Summary This open-label, first-in-human phase 1 dose-escalation trial evaluated the DNA vaccine pEVAC-PS, a computationally designed pan-sarbecovirus candidate delivered intradermally by needle-free PharmaJet Tropis in...

21 July, 2026

2 min read

GHP News

National Academy of Medicine (NAM) – is big tech partnership a bridge to reliable health information, or a reputational risk?

Summary In a NEJM Perspective, Victor Dzau and Laura DeStefano of the National Academy of Medicine (NAM) describe two public–private collaborations aimed at improving reliable health information on major digital...

21 July, 2026

2 min read

GHP News Latest Science

Vaccines return $16 for every $1 invested, but the era of dramatic cost savings may be fading

Summary This global economic modeling study evaluated 50 years (1974–2024) of the WHO Expanded Programme on Immunization (EPI) across 194 WHO member states and 14 pathogens, using a societal-perspective cost model and...

21 July, 2026

2 min read

GHP News Latest Science

Dual influenza subtype positivity is linked to more severe pneumonia, but is it true co-infection or a dataset artifact?

Summary This retrospective single-center study (Guangyuan, China, September 2024–March 2025) linked clinical and BALF targeted-NGS pathogen data in 97 adults hospitalized with influenza-associated CAP. There were 51...

21 July, 2026

2 min read

GHP News Latest Science

Old epilepsy drug repurposed as a low-cost metabolic vaccine booster increases T-cell responses 10-fold in a human trial

Summary A multiomic screen matched T-cell memory transcriptional signatures against >30,000 drug perturbation profiles, identifying lysine deacetylase inhibitors (KDACi) as candidate immunometabolic adjuvants. Low...

21 July, 2026

2 min read

GHP News Latest Science

ViVa news week 29 (July 20, 2026)

New Zealand — HPV schedule change takes effect From 27 July 2026, New Zealand’s school-based HPV program will shift to a single dose of Gardasil 9 with parental consent; dose 2 will still be free but will be...

20 July, 2026

6 min read

GHP News Latest Science

Global child vaccination rates tick up, but millions still left Unprotected — WHO/UNICEF

Geneva/New York, July 15, 2026 — Global childhood immunization coverage edged higher in 2025, but progress remains fragile and uneven, with 13.5 million children receiving zero vaccine doses and measles outbreaks...

16 July, 2026

3 min read

GHP News Latest Science

Measles masquerading as “just fever” in nearly a third of Tanzanian cases — no rash, no suspicion, worse outcomes, and a diagnosis missed for two months

Summary This prospective case-control study enrolled 258 febrile inpatients and 48 controls at a rural Tanzanian hospital over one year (2023-2024), testing blood by PCR for 35 pathogens, culture, and serology. Measles...

15 July, 2026

2 min read

GHP News Latest Science

ViVa 28 feature: Universal influenza vaccines – more than just “broader immunity”

Why We Need a Universal Influenza Vaccine Every year, millions of people roll up their sleeves for a flu shot, and every year, that same shot needs reformulating. This isn’t bureaucratic inefficiency — it’s...

15 July, 2026

5 min read

GHP News Latest Science

ViVa News — Week 28

Shigella vaccine breakthrough The live-attenuated oral Shigella sonnei vaccine WRSs2 reported 89% efficacy against shigellosis in a phase 2 controlled human infection trial — the highest protection rate ever recorded...

15 July, 2026

2 min read